TEXT-S&P assigns Par Pharmaceutical prelim 'B+' rating
Sept 18 - Standard & Poor's Ratings Services said today that all of its preliminary ratings, including its preliminary 'B+' corporate credit rating, on Woodcliff Lake, N.J.-based pharmaceutical company Par Pharmaceutical Companies Inc. remain unchanged following a change to deal terms. The changes include the $75 million upsize to the term loan B, lowered pricing, and an expected improvement to EBITDA beginning in 2013 following a just-announced favorable study result. The additional proceeds fr
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here